Cargando…
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alc...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283830/ https://www.ncbi.nlm.nih.gov/pubmed/30523261 http://dx.doi.org/10.1038/s41467-018-07402-8 |
_version_ | 1783379226835025920 |
---|---|
author | Sun, Hanyong Yang, Weiqin Tian, Yuan Zeng, Xuezhen Zhou, Jingying Mok, Myth T. S. Tang, Wenshu Feng, Yu Xu, Liangliang Chan, Anthony W. H. Tong, Joanna H. Cheung, Yue-Sun Lai, Paul B. S. Wang, Hector K. S. Tsang, Shun-Wa Chow, King-Lau Hu, Mengying Liu, Rihe Huang, Leaf Yang, Bing Yang, Pengyuan To, Ka-Fai Sung, Joseph J. Y. Wong, Grace L. H. Wong, Vincent W. S. Cheng, Alfred S. L. |
author_facet | Sun, Hanyong Yang, Weiqin Tian, Yuan Zeng, Xuezhen Zhou, Jingying Mok, Myth T. S. Tang, Wenshu Feng, Yu Xu, Liangliang Chan, Anthony W. H. Tong, Joanna H. Cheung, Yue-Sun Lai, Paul B. S. Wang, Hector K. S. Tsang, Shun-Wa Chow, King-Lau Hu, Mengying Liu, Rihe Huang, Leaf Yang, Bing Yang, Pengyuan To, Ka-Fai Sung, Joseph J. Y. Wong, Grace L. H. Wong, Vincent W. S. Cheng, Alfred S. L. |
author_sort | Sun, Hanyong |
collection | PubMed |
description | Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alcoholic steatohepatitis (NASH)-related hepatocarcinogenesis. Lentivirus-mediated Ccrk ablation in liver of male mice fed with high-fat high-carbohydrate diet abrogates not only obesity-associated lipid accumulation, glucose intolerance and insulin resistance, but also HCC development. Mechanistically, CCRK fuels a feedforward loop by inducing STAT3-AR promoter co-occupancy and transcriptional up-regulation, which in turn activates mTORC1/4E-BP1/S6K/SREBP1 cascades via GSK3β phosphorylation. Moreover, hepatic CCRK induction in transgenic mice stimulates mTORC1-dependent G(−)csf expression to enhance polymorphonuclear myeloid-derived suppressor cell recruitment and tumorigenicity. Finally, the STAT3-AR-CCRK-mTORC1 pathway components are concordantly over-expressed in human NASH-associated HCCs. These findings unveil the dual roles of an inflammatory-CCRK circuitry in driving metabolic and immunosuppressive reprogramming through mTORC1 activation, thereby establishing a pro-tumorigenic microenvironment for HCC development. |
format | Online Article Text |
id | pubmed-6283830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62838302018-12-10 An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma Sun, Hanyong Yang, Weiqin Tian, Yuan Zeng, Xuezhen Zhou, Jingying Mok, Myth T. S. Tang, Wenshu Feng, Yu Xu, Liangliang Chan, Anthony W. H. Tong, Joanna H. Cheung, Yue-Sun Lai, Paul B. S. Wang, Hector K. S. Tsang, Shun-Wa Chow, King-Lau Hu, Mengying Liu, Rihe Huang, Leaf Yang, Bing Yang, Pengyuan To, Ka-Fai Sung, Joseph J. Y. Wong, Grace L. H. Wong, Vincent W. S. Cheng, Alfred S. L. Nat Commun Article Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alcoholic steatohepatitis (NASH)-related hepatocarcinogenesis. Lentivirus-mediated Ccrk ablation in liver of male mice fed with high-fat high-carbohydrate diet abrogates not only obesity-associated lipid accumulation, glucose intolerance and insulin resistance, but also HCC development. Mechanistically, CCRK fuels a feedforward loop by inducing STAT3-AR promoter co-occupancy and transcriptional up-regulation, which in turn activates mTORC1/4E-BP1/S6K/SREBP1 cascades via GSK3β phosphorylation. Moreover, hepatic CCRK induction in transgenic mice stimulates mTORC1-dependent G(−)csf expression to enhance polymorphonuclear myeloid-derived suppressor cell recruitment and tumorigenicity. Finally, the STAT3-AR-CCRK-mTORC1 pathway components are concordantly over-expressed in human NASH-associated HCCs. These findings unveil the dual roles of an inflammatory-CCRK circuitry in driving metabolic and immunosuppressive reprogramming through mTORC1 activation, thereby establishing a pro-tumorigenic microenvironment for HCC development. Nature Publishing Group UK 2018-12-06 /pmc/articles/PMC6283830/ /pubmed/30523261 http://dx.doi.org/10.1038/s41467-018-07402-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Sun, Hanyong Yang, Weiqin Tian, Yuan Zeng, Xuezhen Zhou, Jingying Mok, Myth T. S. Tang, Wenshu Feng, Yu Xu, Liangliang Chan, Anthony W. H. Tong, Joanna H. Cheung, Yue-Sun Lai, Paul B. S. Wang, Hector K. S. Tsang, Shun-Wa Chow, King-Lau Hu, Mengying Liu, Rihe Huang, Leaf Yang, Bing Yang, Pengyuan To, Ka-Fai Sung, Joseph J. Y. Wong, Grace L. H. Wong, Vincent W. S. Cheng, Alfred S. L. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title_full | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title_fullStr | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title_full_unstemmed | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title_short | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
title_sort | inflammatory-ccrk circuitry drives mtorc1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283830/ https://www.ncbi.nlm.nih.gov/pubmed/30523261 http://dx.doi.org/10.1038/s41467-018-07402-8 |
work_keys_str_mv | AT sunhanyong aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangweiqin aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tianyuan aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT zengxuezhen aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT zhoujingying aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT mokmythts aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tangwenshu aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT fengyu aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT xuliangliang aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chananthonywh aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tongjoannah aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT cheungyuesun aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT laipaulbs aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wanghectorks aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tsangshunwa aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chowkinglau aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT humengying aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT liurihe aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT huangleaf aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangbing aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangpengyuan aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tokafai aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT sungjosephjy aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wonggracelh aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wongvincentws aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chengalfredsl aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT sunhanyong inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangweiqin inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tianyuan inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT zengxuezhen inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT zhoujingying inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT mokmythts inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tangwenshu inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT fengyu inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT xuliangliang inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chananthonywh inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tongjoannah inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT cheungyuesun inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT laipaulbs inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wanghectorks inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tsangshunwa inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chowkinglau inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT humengying inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT liurihe inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT huangleaf inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangbing inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT yangpengyuan inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT tokafai inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT sungjosephjy inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wonggracelh inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT wongvincentws inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma AT chengalfredsl inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma |